On the other hand, the TMZ-sensitive cells secreted high levels of IGFBP6, whereas IGFBP6 was almost undetectable in the supernatants of the TMZ-resistant glioma cells (Fig. 3a). The gene discussed is IGFBP6; the disease is central nervous system cancer.